Publications by authors named "E Ophir"

Claim this Profile
T
The inhibitory receptor PVRIG is dominantly expressed in the bone marrow of patients with multiple myeloma and its blockade enhances T-cell engager's immune activation.
Masha Frenkel, Zoya Alteber, Ning Xu, Mingjie Li, Haiming Chen, Eran Ophir

Exp Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food insecurity amongst asylum seekers and people without status in Israel.
Moran Blaychfeld-Magnazi, Zohar Mor, Gaya Sartena, Rebecca Anne Goldsmith, Einat Ophir

Isr J Health Policy Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PVRIG is Expressed on Stem-Like T Cells in Dendritic Cell-Rich Niches in Tumors and Its Blockade May Induce Immune Infiltration in Non-Inflamed Tumors.
Zoya Alteber, Gady Cojocaru, Roy Z Granit, Inbal Barbiro, Assaf Wool, Eran Ophir

Cancer Immunol Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unleashing Natural IL18 Activity Using an Anti-IL18BP Blocker Induces Potent Immune Stimulation and Antitumor Effects.
Assaf Menachem, Zoya Alteber, Gady Cojocaru, Tal Fridman Kfir, Dan Blat, Eran Ophir

Cancer Immunol Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 pandemic on breastfeeding in Israel: a cross- sectional, observational survey.
Moran Blaychfeld Magnazi, Gaya Sartena, Michal Goldberg, Deena Zimmerman, Einat Ophir

Int Breastfeed J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis